These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12188290)

  • 1. B22956/1, a new intravascular contrast agent for MRI: first administration to humans--preliminary results.
    La Noce A; Stoelben S; Scheffler K; Hennig J; Lenz HM; La Ferla R; Lorusso V; Maggioni F; Cavagna F
    Acad Radiol; 2002 Aug; 9 Suppl 2():S404-6. PubMed ID: 12188290
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
    Pradella S; Lucarini S; Colagrande S
    AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRI.
    Canet EP; Casali C; Desenfant A; An MY; Corot C; Obadia JF; Revel D; Janier MF
    Magn Reson Med; 2000 Mar; 43(3):403-9. PubMed ID: 10725883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo hepatic transport of the magnetic resonance imaging contrast agent B22956/1: role of MRP proteins.
    Lorusso V; Pascolo L; Fernetti C; Visigalli M; Anelli P; Tiribelli C
    Biochem Biophys Res Commun; 2002 Apr; 293(1):100-5. PubMed ID: 12054569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR angiography with a new rapid clearance blood pool agent (P792): initial experience in rabbits.
    Ruehm SG; Schmitz-Cristina H; Violas X; Corot C; Debatin JF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S407-8. PubMed ID: 12188291
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CAM cancer xenograft as a model for initial evaluation of MR labelled compounds.
    Zuo Z; Syrovets T; Wu Y; Hafner S; Vernikouskaya I; Liu W; Ma G; Weil T; Simmet T; Rasche V
    Sci Rep; 2017 May; 7():46690. PubMed ID: 28466861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent.
    Delfino R; Altissimo M; Menk RH; Alberti R; Klatka T; Frizzi T; Longoni A; Salomè M; Tromba G; Arfelli F; Clai M; Vaccari L; Lorusso V; Tiribelli C; Pascolo L
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):834-45. PubMed ID: 21957877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
    Berger F; Kubik-Huch RA; Niemann T; Schmid HR; Poetzsch M; Froehlich JM; Beer JH; Thali MJ; Kraemer T
    Radiology; 2018 Sep; 288(3):703-709. PubMed ID: 29737953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using semiquantitative evaluation.
    Niedermayer S; Prompona M; Cyran CC; Reiser M; Huber A
    J Magn Reson Imaging; 2014 Jan; 39(1):203-10. PubMed ID: 24123355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver.
    Libra A; Fernetti C; Lorusso V; Visigalli M; Anelli PL; Staud F; Tiribelli C; Pascolo L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):809-17. PubMed ID: 16895978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of the MRI contrast agent gadoversetamide injection (OptiMARK) in healthy pediatric subjects.
    Baker JF; Kratz LC; Stevens GR; Wible JH
    Invest Radiol; 2004 Jun; 39(6):334-9. PubMed ID: 15167099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential fast 3D MRI following oral ingestion of Gd-DOTA: A new means to assess intestinal transit time.
    Patak MA; Weishaupt D; Fröhlich JM; Debatin JF
    J Magn Reson Imaging; 1999 Sep; 10(3):474-6. PubMed ID: 10508311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging technics for MRI].
    Yoshikawa K
    Rinsho Hoshasen; 1988 Oct; 33(11):1211-7. PubMed ID: 3225914
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
    Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
    Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic T1 functional MRI examinations with use of blood pool contrast agent--an approach to optimization of the technique.
    Majos A; Wolak T; Sapieha M; Olszycki M; Bogorodzki P; Stefańczyk L
    Clin Imaging; 2011; 35(5):385-90. PubMed ID: 21872129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.